Literature DB >> 847229

Ductus arteriosus responses to prostaglandin E1 at high and low oxygen concentrations.

R I Clyman, M A Heymann, A M Rudolph.   

Abstract

It previously has been suggested that prostaglandin E1 (PGE1) relaxes the ductus arteriosus in a low but not in an elevated oxygen environment. However, in the experiments reported here PGE1 relaxed rings on fetal lamb ductus arteriosus in vitro at both low (14 to 20 torr) and high (680 to 720 torr) oxygen tensions. The threshold concentration for PGE1 was 10(-10) M in either PO2 and the ED50's of PGE1 relaxation in high and low oxygen were 8.5 +/- 3.4 x 10(-10) M and 5.5 +/- 0.7 x 10(-10) M respectively. The magnitude of the relaxation was greater for the oxygen contracted ductus arteriosus than for that exposed to low oxygen. It is suggested that earlier reports of the lack of response of the ductus arteriosus to PGE1 in a high oxygen environment following relaxation in a low oxygen environment may be related to loss of response of the ductus arteriosus to repeated doses of PGE1 rather than to differences in PO2. Prostaglandin E1 therefore may play a significant role in the regulation of ductus arteriosus tone in the elevated oxygen environment of the newborn as well as the low oxygen environment of the fetus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 847229     DOI: 10.1016/0090-6980(77)90003-x

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

Review 1.  Patent ductus arteriosus: experimental aspects.

Authors:  J C Mott
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

Review 2.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

3.  Responses of the post-term arterial duct to oxygen, prostaglandin E2, and the nitric oxide donor, 3-morpholinosydnonimine, in lambs and their clinical implications.

Authors:  S E Abrams; K P Walsh; S J Coker; M J Clarkson
Journal:  Br Heart J       Date:  1995-02

4.  Effect of prostaglandin on early surgical mortality in obstructive lesions of the systemic circulation.

Authors:  F Leoni; J C Huhta; J Douglas; R MacKay; M R de Leval; F J Macartney; J Stark
Journal:  Br Heart J       Date:  1984-12

5.  Prostaglandin E1 in suspected ductus dependent cardiac malformation.

Authors:  K A Hallidie-Smith
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

6.  Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice.

Authors:  Jianhe Huang; Lan Cheng; Jian Li; Mary Chen; Deying Zhou; Min Min Lu; Aaron Proweller; Jonathan A Epstein; Michael S Parmacek
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Indomethacin for symptomatic patent ductus arteriosus in preterm infants.

Authors:  Peter Evans; Deirdre O'Reilly; Jonathan N Flyer; Roger Soll; Souvik Mitra
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

8.  Ibuprofen Versus Indomethacin for Medical Closure of the Patent Arterial Duct: A Pooled Analysis by Route of Administration.

Authors:  Rohit Loomba; Karan Nijhawan
Journal:  Cureus       Date:  2015-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.